Sorrento Therapeutics Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sorrento Therapeutics Inc

SRNE 0.00180

0.0%

Dec 22 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Julius Wong	7/31/2020 7:58:21 AM
	of 171

Analysts’ Top Healthcare Picks: Infinity Pharma (INFI), Sorrento Therapeutics (SRNE) July 31, 2020 Healthcare, Top Market News 0 Comments Analysts’ Top Healthcare Picks: Infinity Pharma (INFI), Sorrento Therapeutics (SRNE)By Jason Carr Sorrento Therapeutics (SRNE) H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Sorrento Therapeutics today and set a price target of $30.00. The company’s shares closed last Thursday at $8.55. According to TipRanks.com, Selvaraju is a top 100 analyst with an average return of 30.4% and a 54.5% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Taro Pharmaceutical Industries, Black Diamond Therapeutics, and Turning Point Therapeutics. analystratings.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next